{"id":"NCT00890721","sponsor":"Pacira Pharmaceuticals, Inc","briefTitle":"Study of Pain Control in Hemorrhoidectomy","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2009-11","completion":"2009-11","firstPosted":"2009-04-30","resultsPosted":"2013-08-06","lastUpdate":"2013-08-06"},"enrollment":189,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hemorrhoid"],"interventions":[{"type":"DRUG","name":"SKY0402","otherNames":["EXPAREL"]},{"type":"DRUG","name":"Placebo","otherNames":["saline 0.9%"]}],"arms":[{"label":"SKY0402","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Patients will get an injection of either SKY0402 or placebo during hemorrhoid surgery, and their pain and pain medicine use will be monitored.","primaryOutcome":{"measure":"The Area Under the Curve (AUC) of the Numeric Rating Scale at Rest (NRS-R) Pain Intensity Scores Through 72 Hours for Subjects Receiving SKY0402 vs. Placebo.","timeFrame":"72 hours","effectByArm":[{"arm":"SKY0402","deltaMin":141.8,"sd":10.7},{"arm":"Placebo","deltaMin":202.5,"sd":10.7}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":16},"locations":{"siteCount":1,"countries":["Poland"]},"refs":{"pmids":["22900785"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":94},"commonTop":["Painful defaecation"]}}